Neuroprotection in Stroke: Past, Present, and Future
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Stroke is a devastating medical condition, killing millions of people each year and causing serious injury to many more. Despite advances in treatment, there is still little that can be done to prevent stroke-related brain damage. The concept of neuroprotection is a source of considerable interest in the search for novel therapies that have the potential to preserve brain tissue and improve overall outcome. Key points of intervention have been identified in many of the processes that are the source of damage to the brain after stroke, and numerous treatment strategies designed to exploit them have been developed. In this review, potential targets of neuroprotection in stroke are discussed, as well as the various treatments that have been targeted against them. In addition, a summary of recent progress in clinical trials of neuroprotective agents in stroke is provided.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Science of Stroke: Mechanisms in Search of Treatments
Moskowitz, M. A., Lo, E. H., & Iadecola, C. (2010) · Neuron · doi:10.1016/j.neuron.2010.07.002 · Cited by 1,930
Inflammatory mechanisms in ischemic stroke: role of inflammatory cells
Jin, R., Yang, G., & Li, G. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.1109766 · Cited by 1,521
Cerebral preconditioning and ischaemic tolerance
Gidday, J. M. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1927 · Cited by 751
Animal models of focal and global cerebral ischemia
Traystman, R. J. (2003) · ILAR Journal · doi:10.1093/ilar.44.2.85 · Cited by 413 · cited 1×
“Several reviews of neuroprotection in both ischemic and hemorrhagic stroke have already been published in the last few years [5–9].”
BackgroundMicroRNA-223 is neuroprotective by targeting glutamate receptors
Harraz, M. M., Eacker, S. M., Wang, X., Dawson, T. M., & Dawson, V. L. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121288109 · Cited by 283 · cited 1×
“The microRNA miR223 reduces expression of the glutamate receptor subunits GluR2 and NR2B, and is neuroprotective against transient global ischemia [58].”
BackgroundNeuroprotection for Ischaemic Stroke: Translation from the Bench to the Bedside
Sutherland, B. A., Minnerup, J., Balami, J. S., Arba, F., Buchan, A. M., & Kleinschnitz, C. (2012) · International Journal of Stroke · doi:10.1111/j.1747-4949.2012.00770.x · Cited by 259 · cited 1×
“The various theories on the reason for this failure have already been discussed elsewhere and will not be covered here [5, 154, 155].”
BackgroundTsc1 (hamartin) confers neuroprotection against ischemia by inducing autophagy
Papadakis, M., Hadley, G., Xilouri, M., Hoyte, L. C., Nagel, S., McMenamin, M. M., Tsaknakis, G., Watt, S. M., Drakesmith, C. W., Chen, R., et al. (2013) · Nature Medicine · doi:10.1038/nm.3097 · Cited by 232 · cited 1×
“Suppression of the TSC1 subunit of this complex has been shown to increase the vulnerability of hippocampal neurons to cell death after ischemia in vivo [79].”
BackgroundXu, M.-F., Xiong, Y.-Y., Liu, J.-K., Qian, J.-J., Zhu, L., & Gao, J. (2012) · Acta Pharmacologica Sinica · doi:10.1038/aps.2012.3 · Cited by 156
Krishnamurthy, R. G., Senut, M., Zemke, D., Min, J., Frenkel, M. B., Greenberg, E. J., Yu, S., Ahn, N., Goudreau, J., Kassab, M., et al. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22071 · Cited by 155
Self-citationThe Potential of Minocycline for Neuroprotection in Human Neurologic Disease
Zemke, D., & Majid, A. (2004) · Clinical Neuropharmacology · doi:10.1097/01.wnf.0000150867.98887.3e · Cited by 125 · cited 1×
“Minocycline is a broad spectrum antibiotic which, in addition to its antibacterial activity, also has anti-inflammatory and antiapoptotic effects [107].”
BackgroundSelf-citation
Cited by
Bernardo-Castro, S., Sousa, J. A., Brás, A., Cecília, C., Rodrigues, B., Almendra, L., Machado, C., Santo, G., Silva, F., Ferreira, L., et al. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.594672 · Cited by 381
The Role of Magnesium in Neurological Disorders
Kirkland, A. E., Sarlo, G. L., & Holton, K. F. (2018) · Nutrients · doi:10.3390/nu10060730 · Cited by 382
“Stroke can be broken down into two types, ischemic (where blood flow is impeded, usually by a clot) and hemorrhagic (where a blood vessel ruptures, causing impaired blood flow in the brain) [175].”
BackgroundPossible Neuroprotective Mechanisms of Physical Exercise in Neurodegeneration
Mahalakshmi, B., Maurya, N., Lee, S.-D., & Bharath Kumar, V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165895 · Cited by 333
Iraci, N., Leonardi, T., Gessler, F., Vega, B., & Pluchino, S. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17020171 · Cited by 301
Uzdensky, A. B. (2019) · Apoptosis · doi:10.1007/s10495-019-01556-6 · Cited by 292
Baek, S.-H., Noh, A. R., Kim, K.-A., Akram, M., Shin, Y.-J., Kim, E.-S., Yu, S. W., Majid, A., & Bae, O.-N. (2014) · Stroke · doi:10.1161/strokeaha.114.005183 · Cited by 174
Self-citationDecoding the Transcriptional Response to Ischemic Stroke in Young and Aged Mouse Brain
Androvic, P., Kirdajova, D., Tureckova, J., Zucha, D., Rohlova, E., Abaffy, P., Kriska, J., Valny, M., Anderova, M., Kubista, M., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107777 · Cited by 118
Metadata
- Authors
- Majid, A.
- Venue
- ISRN Neurology
- Publisher
- Hindawi Limited
- Published
- 2014-01-21
- Volume
- 2014
- Pages
- 1-17
- ISSN
- 2090-5505 (ISSN-L)
- 2090-5513
- OpenAlex
- W1970813943
- Cited by
- 138
- References
- 11
- FWCI
- 11.68
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.